| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6821561 | Schizophrenia Research | 2018 | 6 Pages |
Abstract
Use of amphetamine and cannabis are risk markers for schizophrenia readmission among patients with a history of schizophrenia and DUD. Psychiatric history is a predictor of schizophrenia readmission in this patient group.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Kristine Rømer Thomsen, Birgitte Thylstrup, Michael Mulbjerg Pedersen, Mads Uffe Pedersen, Erik Simonsen, Morten Hesse,